Cadence Healthcare Ventures — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)David Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)Rohan Seth(Executive Officer)
BoardBlake Wu(Director)Juan-Pablo Mas(Director)
Board seatChristopher Kaster· per SEC Form D · $15.1M raise · filed Sep 2015
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCatalio Capital Management, LPCitta Capital+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.